Suppr超能文献

勘误：IFNA1升高和IL12p40受抑制与COVID-19肺炎持续高炎症相关

Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.

作者信息

Jeon Kyeongseok, Kim Yuri, Kang Shin Kwang, Park Uni, Kim Jayoun, Park Nanhee, Koh Jaemoon, Shim Man-Shik, Kim Minsoo, Rhee Youn Ju, Jeong Hyeongseok, Lee Siyoung, Park Donghyun, Lim Jinyoung, Kim Hyunsu, Ha Na-Young, Jo Hye-Yeong, Kim Sang Cheol, Lee Ju-Hee, Shon Jiwon, Kim Hoon, Jeon Yoon Kyung, Choi Youn-Soo, Kim Hye Young, Lee Won-Woo, Choi Murim, Park Hyun-Young, Park Woong-Yang, Kim Yeon-Sook, Cho Nam-Hyuk

机构信息

Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Front Immunol. 2023 Mar 8;14:1175767. doi: 10.3389/fimmu.2023.1175767. eCollection 2023.

DOI:10.3389/fimmu.2023.1175767
PMID:36969212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10031646/
Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1101808.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fimmu.2023.1101808。]

相似文献

1
Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.勘误：IFNA1升高和IL12p40受抑制与COVID-19肺炎持续高炎症相关
Front Immunol. 2023 Mar 8;14:1175767. doi: 10.3389/fimmu.2023.1175767. eCollection 2023.
2
Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.COVID-19 肺炎中升高的 IFNA1 和受抑制的 IL12p40 与持续的过度炎症有关。
Front Immunol. 2023 Jan 27;14:1101808. doi: 10.3389/fimmu.2023.1101808. eCollection 2023.
3
Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.勘误：过氧化物酶体增殖物激活受体在调节由SARS-CoV-2感染引起的过度炎症中的作用：COVID-19治疗的一个视角。
Front Immunol. 2024 May 8;15:1422261. doi: 10.3389/fimmu.2024.1422261. eCollection 2024.
4
Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.勘误：重症 COVID-19 患者肠道通透性破坏的血浆标志物
Front Immunol. 2021 Oct 4;12:779064. doi: 10.3389/fimmu.2021.779064. eCollection 2021.
5
Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.勘误：病例报告：两名长期新冠患者组织中存在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒的残留抗原和RNA
Front Immunol. 2022 Oct 6;13:1036894. doi: 10.3389/fimmu.2022.1036894. eCollection 2022.
6
Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.勘误：羟氯喹对严重急性呼吸综合征冠状病毒2型抗体反应的影响
Front Immunol. 2020 Nov 2;11:615628. doi: 10.3389/fimmu.2020.615628. eCollection 2020.
7
Corrigendum: The effects of COVID-19 on the placenta during pregnancy.勘误：新型冠状病毒肺炎对孕期胎盘的影响。
Front Immunol. 2022 Sep 8;13:998406. doi: 10.3389/fimmu.2022.998406. eCollection 2022.
8
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.勘误：鼻内给予抗CD3单克隆抗体（福罗单抗）可降低轻至中度新冠肺炎患者的肺部炎症和血液炎症生物标志物：一项初步研究。
Front Immunol. 2022 Jan 12;12:815812. doi: 10.3389/fimmu.2021.815812. eCollection 2021.
9
Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?勘误：维生素D状态会影响SARS-CoV-2疫苗的血清转化吗？
Front Immunol. 2023 May 3;14:1210147. doi: 10.3389/fimmu.2023.1210147. eCollection 2023.
10
Corrigendum: Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequelae of SARS-CoV-2 infection.勘误：新型冠状病毒肺炎感染后急性后遗症患者中低密度粒细胞的表型改变。
Front Immunol. 2023 Apr 28;14:1209624. doi: 10.3389/fimmu.2023.1209624. eCollection 2023.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验